Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study). (Q34455177)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study). |
scientific article |
Statements
1 reference
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study). (English)
1 reference
Channa Debruyne
1 reference
Paul B Chapman
1 reference
Stefan C Grant
1 reference
Michael Millward
1 reference
Luc Thiberville
1 reference
Giannicola D'addario
1 reference
Corneel Coens
1 reference
Lisa S Rome
1 reference
Petr Zatloukal
1 reference
Oriol Masso
1 reference
Catherine Legrand
1 reference
1 October 2005
1 reference
1 reference
23
1 reference
28
1 reference
6854-6864
1 reference
Identifiers
1 reference
1 reference